Update on the management of refractory coeliac disease

Journal of Gastrointestinal and Liver Diseases

Volumn 16, Issue 1, 2007, Pages 57-63

  Al toma, Abdulbaqi ^a   Verbeek, Wieke H M ^a   Mulder, Chris J J ^a,b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Coeliac disease; Diagnosis; Pathogenesis; Refractory coeliac disease; Therapy

Indexed keywords

AZATHIOPRINE; BUDESONIDE; CLADRIBINE; CORTICOSTEROID; CYCLOSPORIN A; FLUDARABINE; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; MELPHALAN; TACROLIMUS;

CELIAC DISEASE; DIAGNOSTIC PROCEDURE; DIET THERAPY; DOUBLE BALLOON ENTEROSCOPY; ENDOSCOPY; FLOW CYTOMETRY; FOLLOW UP; HUMAN; INTESTINE MUCOSA; LYMPHOCYTE; REVIEW; STEM CELL TRANSPLANTATION; T LYMPHOCYTE;

CELIAC DISEASE; HUMANS;

EID: 34047262838     PISSN: 18418724     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. United European Gastroenterology Week in Amsterdam 2001. When is a coeliac a coeliac? Eur J Gastroenterol Hepatol 2001; 13:1123-1128.
2. Schuppan D, Kelly CP, Krauss N. Monitoring non-responsive patients with celiac disease. Gastrointest Endosc Clin N Am 2006;16:593-603.
3. Wahab PJ, Crusius JB, Meijer JW, Mulder CJJ. Gluten challenge in borderline gluten-sensitive enteropathy. Am J Gastroenterol 2001;96:1464-1469.
4. Abdulkarim AS, Burgart LJ, See J, Murray JA. Etiology of nonresponsive celiac disease: results of a systematic approach. Am J Gastroenterol 2002; 97:2016-2021.
5. Cellier C, Delabesse E, Helmer C et al. Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group. Lancet 2000; 356: 203-208.
6. Daum S, Cellier C, Mulder CJ. Refractory coeliac disease. Best Pract Res Clin Gastroenterol 2005;19:413-424.
7. Marsh MN. Gluten, major histocompatibility complex and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). Gastroenterology 1992;102:330-354.
8. Van Belzen MJ, Meijer JW, Sandkuijl LA et al. A major non-HLA locus in celiac disease maps to chromosome 19. Gastroenterology 2003;125: 1032-1041.
9. Mazzarella G, Maglio M, Paparo F, et al. An immunodominant DQ8 restricted gliadin peptide activates small intestinal immune response in in vitro cultured mucosa from HLA-DQ8 positive but not HLA-DQ8 negative coeliac patients. Gut 2003;52:57-62.
10. Karell K, Louka AS Moodie SJ et al. European genetics cluster on celiac disease. HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease. Hum Immunol 2003;64: 469-477
11. Al-Toma A, Goerres MS, Meijer JW, Pena AS, Crusius JB, Mulder CJ. Human leukocyte antigen-DQ2 homozygosity and the development of refractory celiac disease and enteropathy-associated T-cell lymphoma. Clin Gastroenterol Hepatol 2006;4:315-319.
12. Vahedi K, Mascart F, Mary JW et al. Reliability of anti-transglutaminase antibodies as predictors of gluten-free diet compliance in adult celiac disease. Am J Gastroenterol 2003;98: 1079-1087.
13. Mulder CJ, Harkemar JM Meijer JW, De Boer NK. Microscopic colitis. Rom J Gastroenterol 2004;13: 113-117.
14. Chott A, dragosics B, Radaszkiewicz T. Peripheral T-cell lymphomas of the intestine. Am J Pathol 1992;141:1361-1371.
15. Daum S, ullrich R Heise W et al. Intestinal non-Hodgkin's lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin's Lymphoma. J Clin Oncol 2003;21: 2740-2746.
16. Schmitt-Gräff A, Hummel M. Zemlin M et al. Intestinal T-cell lymphoma: a reassessment of cytomorphological and phenotype features in relation to patterns of small bowel remodelling. Virch Arch 1996;429:27-36.
17. Tomei E, Diacinti D, Marini M et al. Abdominal CT findings may suggest coeliac disease. Dig Liver Dis 2005;37:402-406.
18. Hadithi M, Mallant M, Oudejans J, van Waesberghe JH, Mulder CJ, Comans EF. 18-F-FDG PET versus CT for the detection of enteropathy-associated T-cell lymphoma in refractory celiac disease. J Nucl Med 2006;47:1622-1627
19. Yamamoto H, Sekine Y, Sato Y, et al. Total enteroscopy with a nonsurgical steerable double-balloon method. Gastrointest Endosc 2001;53:216-20.
20. Ell C, May A, Nachbar L, et al. Push-and-pull enteroscopy in the small bowel using the double-balloon technique: Results of a prospective European multicenter study. Endoscopy 2005;37:613-616.
21. Ashton-Key M, Diss T, Pan L, Du MQ, Isaacson PG. Molecular analysis of T-cell clonality in ulcerative jejunitis and enteropathy-associated T-cell lymphoma. Am J Pathol 1997; 151: 493-498
22. Verkarre V, Asnafi V Lecomte T et al. Refractory coeliac disease is a diffuse gastrointestinal disease. Gut 2003; 52:205-211
23. Vader W, Stepniak D, Kooy Y et al.The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses. Proc Natl Acad Sci U S A 2003 14;100:12390-12395.
24. Bagdi E, Diss TC, Munson P, Isaacson PG. Mucosal intra-epithelial lymphocytes in enteropathy-associated T-cell lymphoma, ulcerative jejunitis, and refractory celiac disease constitute a neoplastic population. Blood 1999; 94:260-264
25. Blumberg RS, Yockey CE, Gross GG, Ebert EC, Balk SP. Human intestinal intraepithelial lymphocytes are derived from a limited number of T cell clones that utilize multiple V beta T cell receptor genes. J Immunol 1993;150:5144-5153.
26. Goerres MS, Meijer JW, Wahab PJ et al, Azathioprine and prednisone combination therapy in refractory coeliac disease. Aliment Pharmacol Ther 2003; 18:487-494
27. Wahab PJ, Crusius JB, Meijer JW, Uil JJ, Mulder CJ. Cyclosporin in the treatment of adults with refractory coeliac disease - an open pilot study. Aliment Pharmacol Ther 2000;14: 767-774.
28. Gillet HR, Arnott IDR, McIntyre M et al. Successful infliximab treatment for steroid-refractory celiac disease: a case report. Gastroenterology 2002;122:800-805.
29. Maurino E, Niveloni S, Chernavsky A, et al. Azathioprine in refractory sprue: results from a prospective, open-label study. Am J Gastroenterol 2002;97:2595-602.
30. Turner SM, Moorghen M, Probert CS. Refractory coeliac disease: remission with infliximab and immunomodulators. Eur J Gastroenterol Hepatol 2005;17:667-669
31. Al-Toma A, Goerres MS, Meijer JW. Cladribine therapy in refractory celiac disease with aberrant T cells. Clin Gastroenterol Hepatol 2006;4:1322-1327; quiz 1300.
32. Al-Toma A, Visser O, van Roessel HM et al. Autologous hematopoietic stem cell transplantation in four celiacs with aberrant T-cells. Blood 2006 Oct 26; [Epub ahead of print].